Medical Management News
-
Daxor Corporation to Commence Trading on the Nasdaq Capital Market
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq Capital Market effective at the opening of trading on February 2, 2022, transferring the listing of its common stock from the New York Stock Exchange – American. Daxor’s common stock will continue trading under the ticker symbol ...
-
The Indoor Microbiome and Its Impact on Indoor Environmental Quality
Last year, the U.S. Environmental Protection Agency (EPA) announced the release of a new webpage to provide information about the indoor microbiome. All of the living microorganisms inside of an indoor environment, and their by-products, are collectively known as the indoor microbiome. The indoor microbiome that surrounds each of us is diverse and dynamic, made up of bacteria, viruses, fungi ...
-
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will present a corporate overview at the H.C. Wainwright BioConnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. Mr. Feldshuh will provide company updates and key highlights, including a new patent award and progress ...
-
Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces patient enrollment is complete and data analysis is underway in preparation for publication of the multi-center observational prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health, Wake ...
-
Daxor Awarded New Patent for Blood Volume Guidance Technology to Improve Treatment & Outcomes
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announced that the United States Patent and Trademark Office has issued the company a new patent (U.S. Patent No. 11,204,356 B2) that protects a proprietary clinical guidance system for volume management utilizing unique volume metrics combined with treatment pathways. “We are very excited ...
-
Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 8:15 a.m. (EST). Among other topics, Mr. Casper will provide the company's current perspective on its business and expectations ...
-
Thermo Fisher Scientific to Present at the 2022 Goldman Healthcare CEOs Unscripted Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 2022 Goldman Healthcare CEOs Unscripted Conference on Thursday, January 6, 2022, at 9:00 a.m. (EDT). You can access the webcast of the presentation via the Investors section of our website. About Thermo ...
-
CD Genomics Fully Supports Your Microbiome Research with Comprehensive Sequencing Solutions
CD Genomics is a leading services company committed to providing global customers with the most comprehensive analytic services, including a broad range of microbial genomic solutions to support research and development. The company announced microbiome profiling services, alongside bioinformatic analysis technology to help researchers understand the significance of human and animal microbiota. ...
By CD Genomics
-
CD Formulation: A Leading Manufacturer of Excipients for Pharmaceutical Preparation
Excipients are of vital importance in the process of drug development. A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for excipients, CD Formulation supplies a wide range of excipients for different research purposes, including binders, lubricants, diluents, disintegrants, emulsifiers, plasticizers, surfactants, sweeteners, ...
-
Creative Enzymes Offers the Raw Materials for Sialic Acid Assay Kit Manufacture
Creative Enzymes, the world’s leading diagnostic enzyme production company, has been committed to providing customers with various enzyme products and services for medical and research diagnosis. Relying on its professional team and the most advanced technology, as well as high-quality products and services, it has gained a solid reputation. Recently, Creative Enzymes announced the raw ...
-
LNI donates to support Bukumbi Hospital in Tanzania
This year, LNI wishes to celebrate Christmas with its true spirit: the joy of giving without a thought of getting. We have decided to donate to the Diocesan Missionary Center of Padua in favor of the Bukumbi Hospital in Tanzania. In Tanzania, HIV infection affects on average 4% of the population. The hospital has a therapy and treatment center for AIDS patients and the Diocesan Missionary ...
By LNI Swissgas
-
U.S. FDA approves Xarelto to treat venous thromboembolism (VTE) and to prevent VTE in children
Xarelto is the only Factor Xa anticoagulant FDA approved for pediatric patients and offers a flexible weight-based dosing Xarelto is available in both oral tablet and liquid suspension formulations for use in appropriate children less than 18 years of age Convenient liquid formulation advances standard of care for children; alleviates administration challenges found with injectable ...
By Bayer AG
-
Thermo Fisher Scientific Updates TaqMan SARS-CoV-2 Mutation Panel to Enable Direct Identification of Omicron Variant
Thermo Fisher Scientific, the world leader in serving science, today announced an update to its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to enable direct detection of the Omicron SARS-CoV-2 variant. The panel is designed with a customizable menu of real-PCR genotyping assays to accurately identify known SARS-COV-2 variants in just over an hour. South African researchers first ...
-
Bayer receives positive CHMP opinion for finerenone as a new treatment for adult patients with chronic kidney disease associated with type 2 diabetes
Finerenone, a non-steroidal, selective mineralocorticoid receptor (MR) antagonist, is recommended by CHMP for marketing authorization for the treatment of chronic kidney disease (CKD) associated with type 2 diabetes (T2D) CHMP opinion is based on the results of the Phase III FIDELIO-DKD study investigating the efficacy and safety of finerenone on kidney and cardiovascular outcomes in patients ...
By Bayer AG
-
Making Melbourne the world’s best student city
Free tickets to attractions and experiences, dedicated health support services and support for a week-long celebration at Fed Square were among the initiatives endorsed by Council at Tuesday’s meeting. Last month, there were about 70,000 international students in Melbourne – a 53.5 per cent decrease on March 2019. Lord Mayor Sally Capp said creating opportunities for ...
-
Creative Biostructure Supplies MagHelix™ Zebrafish Screening Platform for Drug Discovery
Creative Biostructure, a biotechnology company specialized in structural science field, applies its expertise in structural biology and membrane proteins to the drug discovery process and has established ultimate platforms for structure accelerated drug discovery. This newly established MagHelix™ Zebrafish Screening Platform is an excellent choice for building disease models and screening ...
-
Makya Webinar 2021
Topic: Makya: AI-driven de novo drug design and multi-parametric optimisation Recording Duration: 56:50 Webinar Start Time: Dec 7, 2021, 10 - 11 AM CET & 5 - 6 PM CET Access to the Recorded ...
By Iktos
-
Spaya Webinar: 2021
Webinar on Spaya: AI-Enhanced Retrosynthesis for Chemists ...
By Iktos
-
Bold target for Christmas giving campaign
The annual campaign raises awareness and funds for charities, not-for-profits and projects that assist people experiencing homelessness across the municipality, including rough sleepers. The 2021 Good Giving Christmas campaign will support: Primary health and social service Youth Projects, which provides free access to health and social care to improve the wellbeing of people who are, ...
-
Phase III trial with Nubeqa (darolutamide) in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer
ARASENS trial demonstrates an increase in overall survival evaluating darolutamide in combination with docetaxel and androgen deprivation therapy (ADT) compared to docetaxel and ADT, a standard of care in metastatic hormone-sensitive prostate cancer (mHSPC) / Bayer plans to present these pivotal data at a forthcoming scientific congress and to discuss them with health authorities / ARASENS is ...
By Bayer AG
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you